Paget's Disease of Bone
Paget’s disease of bone disrupts the normal cycle of bone renewal, causing bones to become weakened and possibly deformed. It most often affects people over 55.
Key points
- Many people have no symptoms at all; when they do, a dull bone pain at night or at rest is the complaint people most often report.
- The disease can involve one bone or several, commonly the pelvis, spine or skull.
- There is no cure, but treatment aims to relieve symptoms and prevent complications; cases without symptoms may only need monitoring.
Medicines listed for Paget’s Disease of Bone
The listed products contain alendronic acid and risedronate, both bisphosphonates that slow the accelerated bone breakdown seen in Paget’s disease of bone. Each is supplied as a tablet. Alendronic acid appears in strengths of 35 mg and 70 mg; risedronate in 35 mg. Together they address the disrupted bone remodelling that underlies the condition.

